Related Experiment Videos
Prospective pricing system and its effect on the principles and practice of infectious diseases
Abstract:
The health care industry in general and hospitals in particular face an uncertain future as the federal government moved with unusual speed to enact sweeping Medicare legislation. These changing patterns of reimbursement reverse key economic incentives by which hospitals have been driven since the federal program for the elderly began 18 years ago. "Reasonable" cost reimbursement has been replaced by a policy that requires Medicare to establish and fix prices in advance, on a cost-per-case basis, using as a measure 467 categories called "diagnosis-related groups." These changes will present new challenges for the health care industry and will need innovative approaches to meet them. The prospective pricing system attempts to reverse the escalation of health care costs. Under this system, hospitals can realize greater profits only by reducing costs, not by incurring them. The prospective payment system will have profound effects on the practice of infectious diseases, and the potential impact on hospitals, the pharmaceutical industry, physicians, and patients will have to be studied in detail.
Insights
New Medicare legislation introduces a prospective payment system, replacing cost-based reimbursement with fixed, diagnosis-related group prices. This shift incentivizes hospitals to control costs for profitability, impacting healthcare providers and patients.
Area of Science:
- Healthcare Economics
- Health Policy
- Hospital Administration
Background:
- The healthcare industry, particularly hospitals, faces significant uncertainty due to recent federal Medicare legislation.
- Traditional reimbursement models based on "reasonable costs" have been replaced, altering fundamental economic incentives for hospitals.
- The implementation of diagnosis-related groups (DRGs) marks a substantial shift in healthcare payment structures.
Purpose of the Study:
- To analyze the impact of the new prospective payment system (PPS) on the healthcare industry.
- To examine how PPS alters hospital economic incentives and operational strategies.
- To identify the challenges and necessary innovations for healthcare providers under the new reimbursement model.
Main Methods:
- Analysis of federal Medicare legislation and its implications for hospital reimbursement.
- Evaluation of the shift from cost-based reimbursement to a prospective pricing system based on diagnosis-related groups (DRGs).
- Assessment of the economic incentives created by the prospective payment system, focusing on cost reduction for profitability.
Main Results:
- The prospective payment system (PPS) replaces "reasonable cost" reimbursement with fixed, case-based payments using 467 diagnosis-related groups (DRGs).
- Hospitals are now incentivized to reduce costs to increase profits, a reversal from previous cost-incurring models.
- The PPS is designed to control the escalation of healthcare costs.
Conclusions:
- The prospective payment system presents new challenges for the healthcare industry, necessitating innovative approaches.
- The system will profoundly affect the practice of infectious diseases and requires detailed study of its impact on hospitals, pharmaceuticals, physicians, and patients.
- Understanding and adapting to these changes is crucial for all stakeholders in the healthcare ecosystem.